HYDROFLUMETHIAZIDE AND RESERPINE Drug Patent Profile
✉ Email this page to a colleague
When do Hydroflumethiazide And Reserpine patents expire, and when can generic versions of Hydroflumethiazide And Reserpine launch?
Hydroflumethiazide And Reserpine is a drug marketed by Usl Pharma and Watson Labs and is included in three NDAs.
The generic ingredient in HYDROFLUMETHIAZIDE AND RESERPINE is hydroflumethiazide; reserpine. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.
Summary for HYDROFLUMETHIAZIDE AND RESERPINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | HYDROFLUMETHIAZIDE AND RESERPINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HYDROFLUMETHIAZIDE AND RESERPINE
US Patents and Regulatory Information for HYDROFLUMETHIAZIDE AND RESERPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Usl Pharma | HYDROFLUMETHIAZIDE AND RESERPINE | hydroflumethiazide; reserpine | TABLET;ORAL | 088195-001 | Oct 26, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Watson Labs | HYDROFLUMETHIAZIDE AND RESERPINE | hydroflumethiazide; reserpine | TABLET;ORAL | 088127-001 | Mar 22, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Watson Labs | HYDROFLUMETHIAZIDE AND RESERPINE | hydroflumethiazide; reserpine | TABLET;ORAL | 088110-001 | Mar 22, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
